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Abstract
Guidelines encourage the use of self monitoring of blood pressure in
pregnancy, and research suggests that women prefer it. ButHodgkinson
and colleagues explain that our enthusiasm may run ahead of the
evidence and call for more research before it is routinely adopted
Self monitoring of blood pressure is increasingly popular with
patients and healthcare professionals. Around a third of people
with hypertension self monitor,1 and measurements are more
accurate than readings taken in clinic.2 Anecdotal reports in the
UK suggest that self monitoring in pregnancy is commonplace,
although no studies have assessed this. A Canadian pilot survey
found that two thirds of women with gestational hypertension
were self monitoring.3 Another small Canadian survey found
that 78% of obstetricians used self monitoring in preference to
ambulatory measurement to check for white coat hypertension
in pregnant women with raised blood pressure.4
Blood pressure guidelines recommend home monitoring for
pregnant women with chronic hypertension and poorly
controlled blood pressure and for women with gestational
hypertension—for example, the 2013 American College of
Obstetricians and Gynaecologists guidelines5—so it is likely
that the practice will become more common. The American
Heart Association, American Society of Hypertension, and
Preventive Cardiovascular Nurses Association joint statement6
and European Society of Hypertension guidelines have
highlighted the importance and potential of self monitoring
blood pressure, with the American guidelines describing it as
“theoretically ideal for monitoring changes in blood pressure
during pregnancy.”7
Although home monitoring in pregnancy may have some
advantages, there are still many unanswered questions about its
use (box 1). We discuss the available evidence on self
monitoring and suggest a way forward.
How many women are affected?
Hypertensive disorders during pregnancy (box 2) are a leading
cause of maternal mortality worldwide.8They are also associated
with fetal growth restriction, low birth weight, preterm delivery,
respiratory distress syndrome, and admission to neonatal
intensive care.9
Substandard care has been identified in 46% of maternal deaths
from pre-eclampsia and 65% of fetal deaths associated with
pre-eclampsia.11 In particular, failures to identify and act on
known risk factors at booking appointments and to recognise
and respond to signs and symptoms from 20 weeks’ gestation
have been noted.
A tenth of women have raised blood pressure (>140/90 mm
Hg), with or without proteinuria, during pregnancy worldwide,12
and the proportion of women with high blood pressure, and risk
factors for high blood pressure, is increasing. Obesity, for
example, is associated with a threefold increase in risk of
pre-eclampsia,13 14 and in the US the percentage of women who
are obese (body mass index >30) or overweight (> 25) has
increased almost 60% in the past 30 years. Similarly, advanced
maternal age is associated with around a 50% increase of
pre-eclampsia,15 and the number of pregnant women over 40 in
the UK has more than doubled in the past 24 years.16
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Box 1: Advantages and disadvantages of home monitoring of blood pressure in pregnancy
Potential advantages
• Increased accuracy
• Patient friendly
• Potential to free healthcare professional time or reduce clinic visits
• Potential to identify white coat hypertension
• May reduce women’s anxiety or medicalisation of care
Potential disadvantages
• Few monitors have been validated for use in pregnancy
• Poor understanding of normal blood pressure in pregnancy
• No diagnostic thresholds from home monitoring to identify pre-eclampsia or gestational hypertension
• False reassurance if woman with white coat hypertension subsequently develops true hypertension in pregnancy
• No evidence that earlier detection of high blood pressure through home monitoring will alter outcomes
• No evidence on optimal frequency and timing of home monitoring
• May increase women’s anxiety or medicalisation of care
Box 2: Types of hypertension during pregnancy
Chronic hypertension—Blood pressure >140/90 mm Hg before 20 weeks or being treated at time of referral to maternity services
Gestational hypertension—New hypertension presenting after 20 weeks without significant proteinuria
Pre-eclampsia—New hypertension presenting after 20 weeks of pregnancy combined with significant proteinuria (protein:creatinine
ratio>30 mg/mmol or validated 24 h urine collection containing >300 mg protein)10
Blood pressure in pregnancy
Pre-eclampsia can manifest long before women experience
physical symptoms,17 18 and there is evidence that women in the
UK develop the condition between antenatal visits. Of 383
women with confirmed eclampsia, 323 (85%) had been seen by
a doctor or midwife in the week before their first convulsion,
but at that point 36 (11%) had neither hypertension nor
proteinuria, 32 (10%) had proteinuria but no hypertension, and
71 (22%) had hypertension alone.19
Current guidelines recommend blood pressure monitoring at
routine antenatal visits with “increased frequency” for those at
higher risk.20 Comprehensive systematic reviews have not
identified any specific screening test for pre-eclampsia
(including those based on demographic characteristics,
biomarkers, and ultrasound screening) that has sufficient
accuracy or cost effectiveness to introduce into clinical practice.
Consequently blood pressure monitoring in clinics remains the
mainstay of pre-eclampsia detection in antenatal care.21 Earlier
identification of rising blood pressure in asymptomatic women
would allow better targeting of resources at those in need of
close monitoring, and self measurement between clinic
appointments could facilitate this.
Clinic measurements are more vulnerable to error than out of
office monitoring; more measurements can be made at home
and white coat hypertension is avoided. The variability of blood
pressure is heightened in pregnancy,22 and debate continues
about what constitutes normal blood pressure in pregnancy and
how this may change by trimester. Reliance on clinic
measurements could lead to unnecessary monitoring or missed
opportunities to detect raised blood pressure, though there is no
reliable evidence of this being the case. Data from ambulatory
monitoring suggest that outcomes in women with white coat
hypertension in pregnancy are similar to those with normal
blood pressure.23
Will women self monitor?
We know pregnant women are willing to undertake repeated
self measurements, comply with monitoring schedules,10 and
are able to accurately record blood pressure data.24 It does not
seem to increase anxiety,25 even if more complex telemonitoring
equipment is used.26 27 Clinicians promoting self monitoring
report being encouraged by women’s cooperation, competence,
and genuine desire to participate in their healthcare.28 29 Over
98% of women with hypertension in pregnancy reported liking
being involved in their blood pressure management.3
Self monitoring of blood pressure in pregnancy is more
acceptable to pregnant women than more frequent clinic visits,30
hospital admission,27 or ambulatory monitoring.31 32 Among 78
healthy pregnant women who evaluated both home and
ambulatory monitors at 35-37 weeks’ gestation, 74 (95%) found
self monitoring of blood pressure (using Omron HEM705CP)
acceptable compared with 61 (78%) for 24 hour ambulatory
monitoring.33 Home monitoring caused less discomfort and
rarely interfered with activities or disturbed sleep.
Is self monitoring accurate?
Despite the large number of home monitors available, few are
validated and deemed accurate for use in pregnancy and
pre-eclampsia. Specific validation of monitors in pregnant
women is important because several monitors validated for
general use have been found to be inaccurate, mostly because
of falsely low readings.34 35 Five monitors have been validated
for home use in pregnancy using widely accepted protocols.36-40
But even validatedmonitors may not be accurate for all pregnant
women—for example, when the accuracy of three commercially
available devices was tested on 55 pregnant women with upper
arm circumference >35 cm, none was accurate.41
How should self monitoring be done?
In essential hypertension, self monitoring for a minimum of
three days and ideally seven days is currently recommended,
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although the evidence underlying this is not particularly
compelling.42 Conclusions from ambulatory monitoring in
pregnancy suggest that a blood pressure of 135/85 mm Hg best
predicts future pregnancy induced hypertension, but the
threshold has not been established firmly.43 44 Clear self
monitoring thresholds for hypertension in pregnancy have not
been established.42 45 Few data are available comparing clinic
thresholds with self monitored blood pressure in pregnancy,
and the studies they are drawn from have important
methodological weaknesses.
At a more basic level incomplete understanding of normal blood
pressure in pregnancy means that any monitoring in pregnancy
is challenging. Blood pressure changes through the trimesters,
falling and then rising again; thus, a woman could have a blood
pressure that starts at 100/70 mm Hg, falls in mid-trimester to
90/60 mm Hg, and then rises to 135/85 mm Hg (for example)
but still be considered within normal limits (<140/90 mm Hg
by clinic measurement). It is unclear whether monitoring
frequency should change if blood pressure rises notably but
remains below the threshold of 140/90 mm Hg.46 Despite this,
at present only the 140/90 mm Hg threshold is accepted for all
trimesters.10 Women with pre-existing hypertension may have
more unpredictable blood pressure in pregnancy because of
stopping treatment or changing to safer medicines in early
pregnancy.
In the absence of clear evidence, there is little guidance on how
often blood pressure should be measured. The US guidelines
recommend that in women with hypertension before pregnancy
“the diagnosis should be confirmed by multiple measurements
and may incorporate home or other out-of-office blood pressure
readings,” but they do not say what this means practically—for
example, how frequently blood pressure should be measured.47
NICE guidelines on hypertension in pregnancy conclude that
research is needed to determine the optimal frequency and
timing of measurement as well as on the best way to detect
proteinuria in women who have existing hypertension or other
known risk factors for pre-eclampsia.48
Does self monitoring affect pregnancy
outcomes?
It is not known whether self monitoring will alter outcomes. In
the UK, a pilot randomised controlled trial in 80 low risk women
included weekly self monitoring combined with a reduced
antenatal visit schedule.49A larger trial did not go ahead, perhaps
because the predicted number of low risk women required to
determine a significant effect was 10 000. A future trial may be
better to focus on the role of self monitoring in a higher risk
group, which would need fewer women because they would be
more likely to benefit.50
Few data exist on the safety of self monitoring, but there are
conflicting reports regarding how well women follow
instructions from healthcare professionals.30 51 In one small
study, womenwho recorded their own blood pressure responded
appropriately by contacting healthcare professionals when
repeated readings were persistently raised.52 However,
researchers found 10 out of 21 pregnant women in another
study36 had poor understanding of the instructions given about
the importance of alerting midwives when their blood pressure
was raised above a threshold. Problems included language
barriers and personal or work commitments.
The bottom line
Self monitoring of blood pressure seems to be feasible and
acceptable to pregnant women. It might make antenatal care
more effective, but we need further research to establish safety
and efficacy, the impact on women and health professionals,
and how best to use the results. If self monitoring becomes
widely used within healthcare systems, such research may be
difficult to undertake. We believe that until the evidence base
is considerably stronger, further implementation of self
monitoring of blood pressure in pregnancy, at least formally by
the NHS, should be delayed.
Nevertheless, the trend towards self monitoring is set to increase,
and it is important to acknowledge this and respect people’s
choices. General practitioners andmidwives need to be sensitive
to this, and could ask women in their care whether they are self
monitoring and, if so, whether they would like to share the
results or receive any help interpreting them. They should also
discuss the uncertainty around how the results are best
interpreted.
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